3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2023

Abstract

The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

Controversial Impact of Vitamin D Supplementation on Reducing Insulin Resistance and Prevention of Type 2 Diabetes in Patients with Prediabetes: A Systematic Review

“…The last and the most important intervention, which was repeatedly combined in randomized trials with vitamin D supplementation in prediabetes populations was educating the participants about diabetes 2 and lifestyle modifications [ 54 , 56 ]. The recommended and most effective method for preventing diabetes 2 developing in patients with prediabetes is lifestyle behavioral change [ 57 ]. Introducing such an important additional intervention into the study design may significantly influence the results and lead to incorrect conclusions.…”

Addressing the Continuum of Dysglycaemia and Vascular Complications in Prediabetes and Type 2 Diabetes: Need for Early and Intensive Treatment

“… 83 Guidelines or expert opinion in Europe and the USA support the use of metformin in this population, and also in women at risk of type 2 diabetes through prior gestational diabetes ( Table 2 ). 94–96 …”

“…83 Guidelines or expert opinion in Europe and the USA support the use of metformin in this population, and also in women at risk of type 2 diabetes through prior gestational diabetes (Table 2). [94][95][96] The DPP did not demonstrate clinical outcomes benefits for any individual study arm, as described above. However, a real-world analysis has shown that the use of metformin in people with prediabetes was associated with a significantly lower (p < 0.001) incidence of new cardiovascular disease for people with BMI ≥35 kg/m 2 (21%) vs <35 kg/m 2 (28%), which is consistent with current guidance in this area.…”

Aproximación Teórica De La Diabetes

“…Cabe destacar que estos altos niveles de incidencia sobre todo en la población infantil y juvenil han conllevado a la American Diabetes Association (ADA) a generar el protocolo de cuidados en diabéticos, el cual incluye recomendaciones prácticas y una guía para la evaluación de la calidad del cuidado, (15). En la diabetes tipo 2 la interacción de factores genéticos y ambientales generan una resistencia a la insulina e incapacidad de las células β del páncreas para el mantenimiento de una secreción adecuada de insulina, esto conduce a una hiperglucemia.…”

“…Es una definición que se emplea para la descripción de todos los componentes bioinformáticos empleados para la atención del paciente diabético, la gestión de servicios y toda la asistencia con equipos para el monitoreo de glucosa sanguínea y de la tendencia a mejorar el estilo de vida como prevención y las terapias apropiadas. Según refiere el autor existen 2 categorías: la administración de insulina por jeringas u otro instrumento (que requiere de la perforación cutánea) y el monitoreo continuo de glucosa sanguínea (BGM) a través de sistemas de registros digitales, de acuerdo a lo expresado por ElSayed, et al (15).…”